|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Intellectual property (net of accumulated amortization of $9,000 and $8,875) as of June 30, 2025 and 2024, respectively | ||||||||||||||||||||
| Trademarks | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Related party loans | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Commitments and contingencies | ||||||||||||||||||||
| Stockholders' deficiency: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 25,000,000 shares authorized, -0- preferred stock shares issued and outstanding as of June 30, 2026 and 2025 | ||||||||||||||||||||
| Common stock, $0.001 par value, 500,000,000 shares authorized 4,400,048 issued and outstanding as of as of June 30, 2026 and 2025 | ||||||||||||||||||||
| Common stock, $0.001 par value, 500,000,000 shares authorized 4,400,048 issued and outstanding as of as of March 31, 2024 and June 30, 2023 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Stock to be issued | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficiency | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficiency | ||||||||||||||||||||
Loading...
